2015/07/27 - Quantum Genomics announces the appointment of Professor Faiez Zannad as its heart failure consultant

Quantum Genomics (Alternext – FR0011648971 – ALQGC)), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, is announcing its collaboration with Professor Faiez Zannad, acting as a specialized consultant, in order to accelerate its developments in the treatment and prevention of heart failure.

Download Press Release